Xu Jing, Peng Chuanqi, Yu Mengxiao, Zheng Jie
Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5). doi: 10.1002/wnan.1453. Epub 2017 Jan 10.
Metal nanoparticles have demonstrated broad and promising biomedical applications in research laboratories, but how to fulfill their promises in the clinical practices demands extensive effort to minimize their non-specific accumulation in the body. In the past 6 years, we have developed a class of renal clearable noble metal nanoparticles with tunable visible and near-infrared emission, which can behave like small molecular contrast agents to be effectively eliminated through the kidneys. By taking advantage of the unique clearance pathway, we were able to gain some fundamental understanding of how engineering nanoparticles cleared out of the body through urinary system. Moreover, they also provided unique opportunities in early cancer detection and kidney functional imaging that were often challenging to be achieved with non-renal clearable nanoparticles and small molecular probes. In this review, we summarize key factors that govern in the renal clearance of luminescent noble metal nanoparticles and their strengths in cancer targeting and kidney functional imaging. At the end, we also outline several key challenges that need to be addressed before they can be considered in the clinical practices. WIREs Nanomed Nanobiotechnol 2017, 9:e1453. doi: 10.1002/wnan.1453 For further resources related to this article, please visit the WIREs website.
金属纳米颗粒在研究实验室中已展现出广泛且前景广阔的生物医学应用,但如何在临床实践中实现这些应用,需要付出大量努力以尽量减少它们在体内的非特异性积累。在过去6年里,我们开发了一类具有可调可见和近红外发射的可经肾脏清除的贵金属纳米颗粒,它们的行为类似于小分子造影剂,能够通过肾脏有效清除。利用这种独特的清除途径,我们得以对工程纳米颗粒如何通过泌尿系统排出体外有了一些基本认识。此外,它们还在早期癌症检测和肾脏功能成像方面提供了独特机遇,而这些对于不可经肾脏清除的纳米颗粒和小分子探针来说往往难以实现。在这篇综述中,我们总结了影响发光贵金属纳米颗粒肾脏清除的关键因素及其在癌症靶向和肾脏功能成像方面的优势。最后,我们还概述了在它们能够被考虑用于临床实践之前需要解决的几个关键挑战。《WIREs纳米医学与纳米生物技术》2017年,9:e1453。doi:10.1002/wnan.1453 有关本文的更多资源,请访问WIREs网站。